logologo
Search anything
Ctrl+K
arrow
WhatsApp Icon

Muthoot Finance targets 2026: dividend, insurance cues

MUTHOOTFIN

Muthoot Finance Ltd

MUTHOOTFIN

Ask AI

Ask AI

Why Muthoot Finance is back on analysts’ radar

Muthoot Finance has seen a fresh round of analyst note updates as brokerages react to changes in assumptions used for valuation and to a set of upcoming board decisions. A key near-term trigger flagged in multiple research updates is a board meeting scheduled for April 10, 2026, to consider an interim dividend for FY 2025-26. The same meeting agenda also includes a proposal to amend the Memorandum of Association to add insurance corporate agency activities to the company’s permitted business objects, as per a company filing referenced in the notes. Alongside these corporate actions, broker commentary across the period shows repeated recalibration of price targets based on inputs such as discount rates, revenue growth, profit margins, and forward P/E assumptions.

Latest brokerage actions and price targets

A snapshot of recent brokerage recommendations shows a mix of upgrades and downgrades, with price targets clustering around ₹4,000 in some updates and higher targets in others. On February 19, Nirmal Bang upgraded Muthoot Finance to “Buy” from “Hold” and set a price target of ₹4,446. On February 13, Phillip Securities downgraded the stock to “Neutral” from “Buy” with a price target of ₹4,000, and ICICI Securities downgraded it to “Hold” from “Add” with the same ₹4,000 target. Jefferies, also on February 13, adjusted its price target to ₹4,750 from ₹4,500 while maintaining a “Buy” stance. Earlier, on December 17, Investec downgraded the stock to “Hold” from “Buy” with a price target of ₹4,000.

DateBrokerageAction / RatingPrice target (₹)
19/02Nirmal BangUpgraded to Buy from Hold4,446
13/02Phillip SecuritiesDowngraded to Neutral from Buy4,000
13/02ICICI SecuritiesDowngraded to Hold from Add4,000
13/02JefferiesKept Buy; target raised4,750
17/12InvestecDowngraded to Hold from Buy4,000

April 10, 2026 board meeting: interim dividend on the agenda

Multiple analyst updates highlighted the April 10, 2026 board meeting as an event that could influence near-term sentiment. As described in the research notes, the board is scheduled to consider an interim dividend for FY 2025-26. The meeting time is specified as 15:00 IST in one update. While the notes do not quantify a dividend amount, the scheduling itself is treated as a tangible corporate action that analysts incorporate into their narrative.

Insurance corporate agency proposal: a new business object

In the same set of updates, analysts cited a proposal to amend the Memorandum of Association to include insurance corporate agency activities. The research notes frame this as an “insurance foray” that could support long-term upside, but they also indicate the fair value estimate remained broadly unchanged around ₹4,042 per share in one of the updates. The change in target in another update is described as a shift from ₹4,102 to ₹4,042, driven by minor changes in valuation inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions.

Other scheduled board items cited by analysts

Beyond the April meeting, analysts referenced earlier board schedules tied to financial reporting and funding decisions. A board meeting was scheduled for February 12, 2026 to consider and approve unaudited financial results for the quarter ended December 31, 2025. Another meeting was scheduled for November 13, 2025 at 10:30 IST to review and approve unaudited financial results for the quarter and half-year ended September 30, 2025. The November agenda, as cited, also included a proposed fund raising via issue of Redeemable Non-Convertible Debentures and a plan to infuse an additional ₹500 crore of equity into wholly owned subsidiary Muthoot Money Limited.

Valuation and growth points mentioned in the notes

The provided material lists several “Rewards” metrics that are often used to explain valuation comfort. It states the stock’s price-to-earnings ratio is 15.4x, below the Indian market level of 24.2x. It also states earnings are forecast to grow 12.74% per year and that earnings grew by 74.6% over the past year. Another stated point is that analysts are in good agreement that the stock price will rise by 20.5%. Separately, one price target note mentions Muthoot Finance trading at 14x P/E at a price of ₹1,980, with a market cap of ₹79,600 crore.

Price levels and course extremes cited

The dataset also includes “Course Extremes” across time frames, showing the stock’s low and high levels over different periods. For the current year, the range is shown as 3,042.1 to 4,149.5. Over one year, the range is 2,027 to 4,149.5, and over 10 years it is 206.5 to 4,149.5. Another line states the stock price is ₹3,432.700 “today,” while a separate April 2026 note cites a trading price of ₹1,980, indicating the content is drawn from different snapshots.

PeriodLowHigh
1 week3,339.33,594
1 month3,339.33,678.5
Current year3,042.14,149.5
1 year2,0274,149.5
5 years911.254,149.5
10 years206.54,149.5

Results-linked updates: what broker notes highlighted

The material includes commentary that Jefferies and Nuvama raised target prices after a “robust Q1FY26 performance,” citing strong growth in gold loan assets, margin expansion, and improved asset quality. It states the stock surged 11.3% to a new 52-week high of ₹2,793.65 on the BSE after the results. Jefferies maintained a “Buy” rating while increasing its target price to ₹2,950 from ₹2,660, and it cited a 90% year-on-year growth in standalone profit to ₹2,046 crore. The same section mentions consolidated AUM was up 42% year-on-year and refers to loan-to-value ratios offering headroom.

Nuvama reiterated “Buy” and raised its target price to ₹2,993 from ₹2,625, and it described consolidated AUM rising 10% quarter-on-quarter and 42% year-on-year, with gold AUM up 40% year-on-year and 10% quarter-on-quarter. The notes also cite recoveries of ₹350 crore, including ₹100 crore from ARC sales, contributing to yield improvement. Another reported number in the same flow is consolidated net profit of ₹1,974 crore for the quarter ended June 30, 2025, up from ₹1,196 crore in the corresponding period last year.

Revenue and other forward indicators mentioned

One forward-looking line in the dataset states that in the next quarter, Muthoot Finance revenue is expected to reach ₹3,642 crore (₹36.42 billion). The broader target framework in a separate forecast-style note lists a 12-month “analyst consensus” range of ₹2,300 to ₹2,600, with a “bear case” of ₹1,400 and a “bull case” of ₹3,000. It also cites a long-term range for 2027-2028 of ₹3,200 to ₹3,800, presented as analyst projections contingent on assumptions stated in that note.

Market impact: how the inputs translate to targets

Across the updates, the dominant pattern is target price movement driven by model inputs rather than a single operational shock. Several notes explicitly attribute target changes to adjustments in discount rate, revenue growth, profit margin, and forward valuation multiples. Corporate events such as the April 10 interim dividend consideration and the proposal to add insurance corporate agency activities act as identifiable milestones that analysts can reference when justifying stance and timelines. The “Rewards” metrics included in the dataset also show how valuation arguments are framed: P/E relative to the broader market, forecast earnings growth, and a recent surge in earnings.

Conclusion

The set of analyst updates on Muthoot Finance shows a market narrative anchored around board-led milestones, valuation assumption tweaks, and results-driven target revisions. The next widely cited corporate event is the April 10, 2026 board meeting to consider an interim dividend for FY 2025-26 and the proposed Memorandum of Association amendment to add insurance corporate agency activities. Other scheduled items referenced in the notes include board consideration of unaudited results (Feb 12, 2026) and earlier funding and subsidiary equity-infusion plans (Nov 13, 2025). Investors tracking the stock will likely focus on the outcomes of these board items and how brokerages update their models following any disclosures.

Frequently Asked Questions

Analyst notes cite a board meeting on April 10, 2026 to consider an interim dividend for FY 2025-26 and a proposal to amend the Memorandum of Association to add insurance corporate agency activities.
Targets cited include ₹4,446 (Nirmal Bang), ₹4,000 (Phillip Securities and ICICI Securities), ₹4,750 (Jefferies), and ₹4,000 (Investec). Separate notes also mention targets such as ₹2,950 (Jefferies) and ₹2,993 (Nuvama) after Q1FY26 results.
The data states a P/E of 15.4x versus 24.2x for the Indian market, and another note mentions the stock at 14x P/E at a price of ₹1,980 with a market cap of ₹79,600 crore.
The notes cite a proposal to raise funds via Redeemable Non-Convertible Debentures and a planned additional equity infusion of ₹500 crore into wholly owned subsidiary Muthoot Money Limited, along with approval of unaudited results.
The dataset states that next quarter revenue is expected to reach ₹3,642 crore (₹36.42 billion).

Did your stocks survive the war?

See what broke. See what stood.

Live Q4 Earnings Tracker